Stanley Lapidus - 20 Feb 2026 Form 4 Insider Report for Lucid Diagnostics Inc. (LUCD)

Role
Director
Signature
/s/ Michael A. Gordon, by power of attorney
Issuer symbol
LUCD
Transactions as of
20 Feb 2026
Net transactions value
$0
Form type
4
Filing time
24 Feb 2026, 18:44:57 UTC
Previous filing
21 Feb 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lapidus Stanley Director 360 MADISON AVENUE, 25TH FLOOR, NEW YORK /s/ Michael A. Gordon, by power of attorney 24 Feb 2026 0001678195

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUCD Common Stock Award $0 +123,000 +57% $0.000000 337,392 20 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed